Prostate Cancer Update
by Dr. Neil Love
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇮🇳IN · Science#7910K to 30K
- 🇵🇭PH · Science#159500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
5.3K to 17K🎙 ~2x weekly·57 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
11K to 33K🇮🇳91%🇵🇭9% - Active Followers
Loyal subscribers who consistently listen
3.1K to 9.9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 20 epsHosts
Recent guests
Recent episodes
Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
Jul 2, 2026
35m 58s
For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
Jul 1, 2026
1h 30m 07s
Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
Jun 25, 2026
57m 36s
Prostate Cancer — Fifth Annual National General Medical Oncology Summit
Jun 23, 2026
49m 54s
Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
Jun 17, 2026
49m 29s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/2/26 | Androgen Deprivation TherapyProstate Cancer+5 | Dr Rana R McKay | relugolixCAR (chimeric antigen receptor) T-cell therapy+4 | — | androgen deprivation therapyprostate cancer+5 | — | 35m 58s | ||
| 7/1/26 | Non-Muscle-Invasive Bladder CancerMuscle-Invasive Bladder Cancer+4 | Dr Alexandra DrakakiMs Krisztina Emodi+1 | ONS Congress | — | bladder cancerurothelial cancer+4 | — | 1h 30m 07s | ||
| 6/25/26 | Urothelial Bladder CancerRadical Cystectomy+5 | Dr Ashish M KamatProf Thomas Powles | Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances | — | urothelial bladder cancerradical cystectomy+5 | — | 57m 36s | ||
| 6/23/26 | Prostate CancerHormonal Therapy+3 | Dr Neeraj AgarwalDr Alan H Bryce | Prostate Cancer UpdateCME | — | Prostate CancerHormonal Therapy+4 | — | 49m 54s | ||
| 6/17/26 | Immunotherapeutic StrategiesNonmetastatic Urothelial Bladder Cancer+3 | Dr Terence FriedlanderDr Daniel P Petrylak | Urothelial Bladder Cancer | — | urothelial bladder cancerimmunotherapy+5 | — | 49m 29s | ||
| 6/16/26 | Prostate CancerHormone-Sensitive Prostate Cancer+4 | Dr Neeraj AgarwalDr Daniel P Petrylak+2 | — | — | Prostate CancerHormone-Sensitive+4 | — | 1h 58m 20s | ||
| 6/12/26 | renal cell carcinomacancer management+3 | Dr Thomas HutsonDr Eric A Singer+1 | Sarah Cannon Research InstituteThe Ohio State University Comprehensive Cancer Center+1 | — | renal cell carcinomacancer treatment+3 | — | 1h 28m 33s | ||
| 6/5/26 | genitourinary cancerscirculating tumor DNA+3 | Professor Thomas Powles | Barts Cancer Institute | London, United Kingdom | circulating tumor DNAurothelial bladder cancer+3 | — | 22m 38s | ||
| 5/26/26 | genitourinary cancerscirculating tumor DNA+3 | Professor Thomas Powles | Barts Cancer Institute | London, United Kingdom | circulating tumor DNAurothelial bladder cancer+3 | — | 29m 57s | ||
| 5/15/26 | PARP inhibitorshormone-sensitive prostate cancer+3 | Dr Wassim Abida | Memorial Sloan Kettering Cancer Center | New York | PARP inhibitorshormone-sensitive+3 | — | 51m 55s | ||
| 4/17/26 | prostate cancertherapy selection+3 | Dr Andrew J ArmstrongDr Scott T Tagawa | Duke Cancer InstituteWeill Cornell Medicine Meyer Cancer Center | Durham, North CarolinaNew York, New York | prostate cancertherapy sequencing+3 | — | 58m 21s | ||
| 4/15/26 | metastatic bladder cancerpatient cases+3 | Dr Matthew Milowsky | UNC Lineberger Comprehensive Cancer CenterEmory University School of Medicine+1 | — | metastatic bladder cancerurothelial cancer+3 | — | 27m 45s | ||
| 3/31/26 | AKT inhibitionprostate cancer+3 | Prof Karim FizaziDr Daniel George | Centre Oscar LambretDuke Cancer Institute+1 | — | AKT inhibitionprostate cancer+3 | — | 1h 29m 22s | ||
| 3/27/26 | metastatic bladder cancerpatient cases+3 | Dr Matthew Milowsky | UNC Lineberger Comprehensive Cancer CenterEmory University School of Medicine+1 | — | metastatic bladder cancerurothelial cancer+3 | — | 32m 43s | ||
| 3/25/26 | bladder cancernon-muscle-invasive cancer+3 | Dr Matthew D GalskyDr Shilpa Gupta+1 | The Tisch Cancer InstituteCleveland Clinic’s Taussig Cancer Institute+2 | — | bladder cancernon-muscle-invasive+3 | — | 1h 58m 06s | ||
| 2/23/26 | bladder cancertherapy selection+3 | Dr Terence Friedlander | — | — | urothelial bladder cancertherapy sequencing+3 | — | 23m 29s | ||
| 2/17/26 | metastatic bladder cancerpatient cases+3 | Dr Fern AnariDr Catherine Fahey | Fox Chase Cancer CenterLineberger Comprehensive Cancer Center+1 | Philadelphia, PennsylvaniaChapel Hill, North Carolina+1 | metastatic bladder cancerpatient cases+3 | — | 29m 11s | ||
| 2/10/26 | prostate cancerandrogen pathway-targeting agents+3 | Dr Rana R McKay | ESMO Congress 2025 | — | prostate cancerandrogen pathway+3 | — | 18m 06s | ||
| 2/4/26 | bladder cancertherapy selection+3 | Dr Terence Friedlander | — | — | urothelial bladder cancertherapy sequencing+3 | — | 31m 09s | ||
| 1/29/26 | prostate cancertherapy selection+3 | Dr Rana R McKay | ESMO Congress 2025 | — | prostate cancertherapy sequencing+3 | — | 18m 08s |
Showing 20 of 20
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Prostate Cancer Update
Peaked at #79 in India, currently #79 in India.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| India | — | #79 | #79 | — |
| PH | — | #159 | #159 | — |
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.